Propynylated phosphodiester oligonucleotides inhibit ICAM-1 expression in A549 cells on electroporation

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 2, 2001, Pages 117-123

  Meunier, L ^a,b   Monsigny, M ^a   Roche, A C ^a  

^a CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXONUCLEASE; INTERCELLULAR ADHESION MOLECULE 1; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CANCER CELL; CHEMICAL MODIFICATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MICROINJECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0035029570     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001750171371     Document Type: Article

References (33)

1. Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
2. Optimized synthesis of phosphorothioate oligodeoxyribonucleotides substituted with a 5′-protected thiol function and a 3′-amino group
3. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides
4. Electroporation of synthetic oligodeoxynucleotides: A novel technique for ex vivo bone marrow purging
5. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms
6. Rapid nuclear accumulation of injected oligodeoxyribonucleotides
7. An overview of progress in antisense therapeutics
8. Progress in antisense oligonucleotide therapeutics
9. Backbone modifications in oligonucleotides and peptide nucleic acid systems
10. Trojan peptides: The penetratin system for intracellular delivery
11. Polyethylenimine but not cationic lipid improves antisense activity of 3′-capped phosphodiester oligonucleotides
12. Phosphorothioate oligodeoxynucleotides: What is their origin and what is unique about them?
13. Intracellular disposition and metabolism of fluorescently labeled unmodified and modified oligonucleotides microinjected into mammalian cells
14. Elucidation of gene function using C-5 propyne antisense oligonucleotides
15. Potent and selective gene inhibition using antisense oligodeoxynucleotides
16. Facilitating oligonucleotide delivery: Helping antisense deliver on its promise
17. Inhibition of gene expression by anti-sense C-5 propyne oligonucleotides detected by a reporter enzyme
18. Fading of immunofluorescence during microscopy: A study of the phenomenon and its remedy
19. Intracellular distribution of microinjected antisense oligonucleotides
20. A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA
21. Inhibition of HIV-1 in vitro by C-5 propyne phosphorothioate antisense to rev
22. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus
23. In pursuit of antisense
24. The nuclear export signal-dependent localization of oligonucleopeptides enhances the inhibition of the protein expression from a gene transcribed in cytosol
25. Current concepts in antisense drug design
26. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides
27. Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide
28. Inhibition of dengue virus by novel, modified antisense oligonucleotides
29. Inhibition of human mammary cell line proliferation by membrane lectin-mediated uptake of Ha-ras antisense oligonucleotides
30. Nuclear delivery of antisense oligodeoxynucleotides through reversible permeabilization of human leukemia cells with streptolysin O
31. Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity
32. Transport of oligonucleotides across natural and model membranes
33. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines